Figure 6From: Efficacy and safety of artemisinin-naphthoquine versus dihydroartemisinin-piperaquine in adult patients with uncomplicated malaria: a multi-centre study in IndonesiaCumulative risk of failure of artemisinin-naphthoquine (AN) versus dihydroartemisinin-piperaquine (DHP) in modified ITT population infected with any malaria. The TF by day 28 and 42 were 2% (4 of 196) and 6.7% (13 of 194) in AN group, and 2.1% (4 of 190) and 5.3% (10 of 190) in DHP group. The hazard ratio of failure between AN and DHP groups was 1.28 (95% CI: 0.56 – 2.92) with p = 0.56.Back to article page